Detalhe da pesquisa
1.
Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism.
Gastroenterology
; 162(2): 590-603.e14, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34627860
2.
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix.
J Clin Invest
; 130(9): 4704-4709, 2020 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32749238